BioProtect has developed a proprietary technology platform for biodegradable balloons. The technology is designed for a wide range of clinical applications, including spacing for radiation oncology protection, aesthetics, and general surgery. The company's first application in the commercialization stage is the BioProtect/ProSpace Balloon System, which acts as a spacer for the protection of healthy tissue in patients receiving radiotherapy for prostate cancer. The product is commercially available in Europe and is undergoing clinical studies in the United States prior to FDA approval. BioProtect has a robust product pipeline developed in consultation with physicians regarding radiotherapy spacing and other unmet clinical needs.